Total Funding
50
64
Total FundingSeries A raised
Growth Score 50 in past quarter
-32 pts
Heat Score 64 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
33326
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
Irving L. Weissman: Co-FounderPast Role: Stem Cell Therapeutics, Director- Georgette Verdin: Chief People OfficerPast Role: Avrobio, Chief Human Resources Officer
About the Company
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.